Gold prices gain as dollar weakness lifts appeal

Author of the article: Gold prices rose on Monday as the U.S. dollar weakened, but recent gains are unlikely to stave off another monthly fall for greenback-priced bullion. Spot gold was up 0.4% at $1,860.77 per ounce, as of 0451 GMT. U.S. gold futures also climbed 0.4% to $1,865.00. “With the three-day holiday in the…
Gold prices gain as dollar weakness lifts appeal

Author of the article:

Gold prices rose on Monday as the U.S.

dollar weakened, but recent gains are unlikely to stave off

another monthly fall for greenback-priced bullion.

Spot gold was up 0.4% at $1,860.77 per ounce, as of

0451 GMT. U.S. gold futures also climbed 0.4% to

$1,865.00.

“With the three-day holiday in the United States, which

means lower liquidity than usual, and a lack of top-tier data

until Wednesday, we may find that gold will remain nailed to its

tight range around $1,850 unless a new catalyst arrives,” City

Index senior market analyst Matt Simpson said.

Federal government offices, stock and bond markets, and the

Federal Reserve will be closed on Monday for the Memorial Day

holiday in the United States.

The dollar eased, making bullion more attractive for

buyers holding other currencies.

Despite a mostly positive showing since hitting an over

three-month low of $1,786.60 per ounce on May 16, gold prices

are on course for a second straight monthly fall for the first

time since March 2021, down about 1.9% so far.

“A large part of gold’s underperformance has been due to

investors moving to cash as equity markets fell, while lockdowns

in China also dented demand. Typically, June is a bearish month

for gold but that seasonal pattern appears to have been shifted

forward by one month,” Simpson said.

Asian equities followed Wall Street higher, as investors

wagered on an eventual slowdown in U.S. monetary tightening,

albeit after sharp hikes in June and July.

Higher short-term U.S. interest rates raise the opportunity

cost of holding non-yielding bullion.

Spot gold is expected to retest a resistance at $1,867 per

ounce, a break above could lead to a gain into $1,887-$1,892

range, according to Reuters’ technical analyst Wang Tao.

Spot silver rose 0.5% to $22.22 per ounce, platinum

firmed 0.4% to $957.58, and palladium gained 0.9%

to $2,079.68.

(Reporting by Bharat Govind Gautam in Bengaluru; Editing by

Sherry Jacob-Phillips, Rashmi Aich and Uttaresh.V)

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Sonoco Raises Second-Quarter 2022 Financial Guidance
Read More

Sonoco Raises Second-Quarter 2022 Financial Guidance

Author of the article: HARTSVILLE, S.C., June 22, 2022 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), one of the largest global sustainable packaging companies, today provided updated guidance for its second quarter net income per diluted share, ending July 3, 2022, and announced its earnings release date and investor conference call information. Sonoco Provides Second-Quarter 2022…
Japanese shares close lower on Ukraine jitters
Read More

Japanese shares close lower on Ukraine jitters

Author of the article: TOKYO — Japanese shares fell on Thursday as risk appetite was curbed by worries surrounding Ukraine, while investors remained concerned over rising interest rates globally to contain broadening inflationary pressures. The Nikkei share average lost 0.83% to close at 27,232.87, while the broader Topix slipped 0.79% to 1,931.24. The Nikkei had…
China approves Brii Biosciences’ COVID-19 treatment
Read More

China approves Brii Biosciences’ COVID-19 treatment

This advertisement has not loaded yet, but your article continues below. Author of the article: Article content BEIJING — China’s medical products regulator said on Wednesday it has approved the use of BRII Biosciences’ neutrialising antibody cocktail for COVID-19, the first treatment of its type against the disease approved in the country. The medicine, a…